Department of Health Services & Outcomes Research, National Healthcare Group, Singapore.
Value Health. 2009 Nov-Dec;12 Suppl 3:S101-5. doi: 10.1111/j.1524-4733.2009.00639.x.
This study aims to assess the impact of diabetes mellitus (DM) on the health-care utilization and clinical outcomes of patients with acute stroke.
This is a retrospective cohort study. All patients who were admitted for the first time to one of the three public hospitals in the National Healthcare Group in Singapore from January 2005 to June 2007 with a primary diagnosis of acute stroke were included and were followed up for 1 year after the index hospitalization. The study population was divided into two groups: with DM and without DM. Both univariate and multivariate analyses were applied to compare the hospital length of stay (LOS), hospitalization costs, mortality, as well as the 1-year hospital readmissions between the DM and non-DM groups.
There were 9766 study patients, and 38.5% of them had DM. DM patients with ischemic stroke (IS) and transient ischemic attack (TIA) stayed 1-day and 0.6-day longer, and incurred 10% and 26% higher hospital cost during index admission, respectively, compared with their counterparts in the non-DM group. They also had more hospital readmission within 1 year. The mortality rate in IS patients with diabetes was 24% higher. After risk adjustment, subarachnoid hemorrhage patients with diabetes had more hospitalizations. Intracerebral hemorrhage (ICH) and IS patients in the DM group had all worse outcomes but the 1-year stroke recurrence; TIA patients with DM incurred longer LOS and hospital costs.
DM predicts worse clinical outcomes and higher health-care expenditures in the 1-year poststroke especially for the IS, ICH, and TIA stroke subtypes.
本研究旨在评估糖尿病(DM)对急性脑卒中患者的医疗保健利用和临床结局的影响。
这是一项回顾性队列研究。纳入 2005 年 1 月至 2007 年 6 月期间首次因急性脑卒中入住新加坡国立医疗保健集团三家公立医院的所有患者,并在索引住院后进行了 1 年的随访。研究人群分为两组:有 DM 和无 DM。应用单变量和多变量分析比较 DM 组和非 DM 组的住院时间(LOS)、住院费用、死亡率以及 1 年内的再次住院情况。
共有 9766 例研究患者,其中 38.5%患有 DM。与非 DM 组相比,缺血性脑卒中(IS)和短暂性脑缺血发作(TIA)合并 DM 的患者住院时间分别延长 1 天和 0.6 天,住院费用分别增加 10%和 26%。他们在 1 年内的再次住院率也更高。合并 DM 的 IS 患者的死亡率高 24%。风险调整后,合并 DM 的蛛网膜下腔出血患者住院次数更多。DM 组的脑出血(ICH)和 IS 患者的所有结局均较差,但 1 年脑卒中复发率除外;DM 组的 TIA 患者的 LOS 和住院费用更长。
DM 预测脑卒中后 1 年内的临床结局较差,医疗保健支出较高,尤其是 IS、ICH 和 TIA 脑卒中亚型。